First human tests begin for new compound TBD09
NCT ID NCT07094932
Summary
This early-stage study aimed to check if a new compound called TBD09 is safe for people and to see how the body processes it. It involved 36 healthy adults who took either TBD09 or a placebo pill daily for 84 days. Researchers closely monitored participants for any side effects and measured drug levels in their blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion
Lincoln, Nebraska, 68502, United States
Conditions
Explore the condition pages connected to this study.